| UniProtKB AC (Name) | UniProtKB Section | Organism | Description | |
|---|---|---|---|---|
| Q2G212 (MNHD2_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Putative antiporter subunit mnhD2; Mrp complex subunit D2; Putative NADH-ubiquinone oxidoreductase subunit mnhD2; | |
| Q2FYZ5 (GLPK_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Glycerol kinase; ATP:glycerol 3-phosphotransferase; Glycerokinase; | |
| Q2FWH5 (CSHA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | DEAD-box ATP-dependent RNA helicase CshA; | |
| Q2FY41 (EFP_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Elongation factor P; | |
| Q2FV42 (Y2897_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | HTH-type transcriptional regulator SAOUHSC_02897; | |
| Q2FWE8 (ATPA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | ATP synthase subunit alpha; ATP synthase F1 sector subunit alpha; F-ATPase subunit alpha; | |
| Q2FYU7 (CATA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Catalase; | |
| Q2FWK3 (LEU1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 2-isopropylmalate synthase; Alpha-IPM synthase; Alpha-isopropylmalate synthase; | |
| Q2FVR1 (HRTA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Putative hemin import ATP-binding protein HrtA; | |
| Q2FY46 (EX7L_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Exodeoxyribonuclease 7 large subunit; Exodeoxyribonuclease VII large subunit; | |
| Q2G2G3 (MNTH_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Divalent metal cation transporter MntH; | |
| Q2G185 (ESSB_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Type VII secretion system protein EssB; | |
| Q2FUS6 (PCP_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Pyrrolidone-carboxylate peptidase; 5-oxoprolyl-peptidase; Pyroglutamyl-peptidase I; | |
| P0C0V7 (GLMM_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Phosphoglucosamine mutase; | |
| Q2G140 (MEPA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Multidrug export protein MepA; Staphylococcal virulence regulator protein A; | |
| Q9KJN3 (ARLS_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Signal transduction histidine-protein kinase ArlS; | |
| Q2FX88 (QUEG_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Epoxyqueuosine reductase; Queuosine biosynthesis protein QueG; | |
| Q2G2L1 (TAGH_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Teichoic acids export ATP-binding protein TagH; | |
| Q2FYR6 (TRPC_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Indole-3-glycerol phosphate synthase; | |
| Q9ZNI1 (LYTN_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Probable cell wall hydrolase LytN; | |
| Q2FVC5 (Y2788_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Uncharacterized lipoprotein SAOUHSC_02788; | |
| Q2G0X0 (Y404_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Uncharacterized lipoprotein SAOUHSC_00404; | |
| Q2FYN6 (Y1399_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Uncharacterized hydrolase SAOUHSC_01399; | |
| Q2FZX0 (NAGD_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Acid sugar phosphatase; | |
| Q2G0T3 (RECR_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Recombination protein RecR; | |
| Q2FZU9 (PPI1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Putative peptidyl-prolyl cis-trans isomerase; Rotamase; | |
| Q2G241 (SYE_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Glutamate--tRNA ligase; Glutamyl-tRNA synthetase; | |
| Q2FWK0 (LEUD_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 3-isopropylmalate dehydratase small subunit; Alpha-IPM isomerase; Isopropylmalate isomerase; | |
| Q2G055 (HPF_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Ribosome hibernation promotion factor; Hibernation promoting factor SaHPF; | |
| Q2G0R9 (PTH_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Peptidyl-tRNA hydrolase; SaPth; | |
| Q2FZF4 (TMCAL_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | tRNA(Met) cytidine acetate ligase; | |
| Q2FXZ3 (DNAJ_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Chaperone protein DnaJ; | |
| Q2G0D4 (SSAAL_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Probable autolysin SsaALP; | |
| Q2FVX3 (FDHD_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Sulfur carrier protein FdhD; | |
| Q2FVH6 (FLP_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Protein flp; FmtA-like protein; | |
| Q2G2H7 (MNHD1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Na(+)/H(+) antiporter subunit D1; Mnh complex subunit D1; | |
| Q2FV57 (CRTP_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 4,4'-diaponeurosporene oxygenase; 4,4'-diaponeurosporene oxidase; Carotenoid oxidase; | |
| Q2FUW3 (ASP1_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Accessory Sec system protein Asp1; Accessory secretory protein Asp1; | |
| Q2FZ77 (PYRR_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Bifunctional protein PyrR; Pyrimidine operon regulatory protein; Uracil phosphoribosyltransferase; UPRTase; 2.4.2.9; | |
| Q2FXP9 (IF3_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Translation initiation factor IF-3; | |
| Q2FUX3 (ISAB_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Immunodominant staphylococcal antigen B; | |
| P0A086 (MSRA2_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Peptide methionine sulfoxide reductase MsrA 2; Peptide-methionine (S)-S-oxide reductase 2; | |
| Q2FZ02 (MIAB_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase; (Dimethylallyl)adenosine tRNA methylthiotransferase MiaB; tRNA-i(6)A37 methylthiotransferase; | |
| Q2FV67 (ROCA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | 1-pyrroline-5-carboxylate dehydrogenase; L-glutamate gamma-semialdehyde dehydrogenase; | |
| Q2FZ29 (HSLV_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | ATP-dependent protease subunit HslV; | |
| O05204 (AHPF_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Alkyl hydroperoxide reductase subunit F; | |
| Q2FWD0 (RPOE_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Probable DNA-directed RNA polymerase subunit delta; RNAP delta factor; | |
| P02976 (SPA_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Immunoglobulin G-binding protein A; Staphylococcal protein A; | |
| Q2FUT1 (Y3020_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | UPF0397 protein SAOUHSC_03020; | |
| Q2FZ21 (RRF_STAA8) | Swiss-Prot | Staphylococcus aureus (strain NCTC 8325 / PS 47) | Ribosome-recycling factor; Ribosome-releasing factor; |
Staphylococcus aureus is a Gram-positive coccal bacterium that is a member of the Firmicutes, and is frequently found in the nose, respiratory tract, and on the skin. Although S. aureus is not always pathogenic, it is a common cause of skin infections such as abscesses, respiratory infections such as sinusitis, and food poisoning.
An estimated 20% of the human population are long-term carriers of S. aureus. It is one of the five most common causes of hospital-acquired infections and is often the cause of postsurgical wound infections. The emergence of antibiotic-resistant strains of S. aureus such as methicillin-resistant S. aureus (MRSA) is a worldwide problem in clinical medicine. There are currently (2016) no dedicated antibiotics against drug-resistant S. aureus available.
The genome of S. aureus was first sequenced in 2006.
From left to right: i) The number of proteins in the reference proteome of Staphylococcus aureus, ii) the number of unique protein sequences for which at least one model is available, iii) the total number of models and iv) a coverage bar plot is shown.
The bar plot shows the coverage for every protein in the reference proteome of Staphylococcus aureus for which there is at least one model. Different colours (dark green to red boxes) represent the coverage of the targets. Targets with high coverage are represented in dark green (more than 80% of the target's length is covered by models), whereas low coverage is shown in red. The size of each box is proportional to the number of target sequences with a given coverage.
For information on the latest proteome for Staphylococcus aureus, please visit UniProtKB.
You can easily download the latest protein sequences for Staphylococcus aureus proteome here. Please note this download is for the current UniProtKB release, which may be different to release 2026_03 that was used for the most up to date SWISS-MODEL Repository.
| Proteins in proteome | Sequences modelled | Models |
| 2,889 | 2,425 | 3,847 |
Detailed coverage numbers are obtained by hovering the mouse over one of the boxes.
The plot shows the evolution over years (x-axis) of the fraction of Staphylococcus aureus reference proteome residues (y-axis) for which structural information is available. Different colors (light blue to dark blue) in the plot represent the quality of the sequence alignment between the reference proteome sequences (targets) and the sequences of the proteins in the structure database (templates). Alignments with low sequence identity are displayed in light blue, whereas alignments with high sequence identity are depicted in dark blue. The SWISS-MODEL Template Library is used as database of templates. Only target-template alignments found by HHblits and only residues with atom coordinates are considered.
This chart shows the percentage of residues in the Staphylococcus aureus proteome which are covered by experimental structures and the enhancement of coverage by homology modelling by the SWISS-MODEL pipeline. Experimental residue coverage is determined using SIFTS mapping. For residues which are not covered by experimental structures (including where there are no atom records in SIFTS mapping) the model coverage bars are coloured by QMEANDisCo local quality score.
Many proteins form oligomeric structures either by self-assembly (homo-oligomeric) or by assembly with other proteins (hetero-oligomeric) to accomplish their function. In SWISS-MODEL Repository, the quaternary structure annotation of the template is used to model the target sequence in its oligomeric form. Currently our method is limited to the modelling of homo-oligomeric assemblies. The oligomeric state of the template is only considered if the interface is conserved.
| Single Chain | 2-mer | 3-mer | 4-mer | 5-mer | 6-mer | 7-mer | 8-mer | 9-mer | 10-mer | 12-mer | 13-mer | 14-mer | 16-mer | 24-mer | 25-mer | 40-mer | 60-mer |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2,426 | 986 | 79 | 209 | 8 | 75 | 6 | 15 | 3 | 8 | 14 | 2 | 5 | 1 | 7 | 1 | 1 | 1 |
